Scientific deep-dive

Green Tea Extract for Weight Loss: A Small Effect and a Liver Risk

Green tea extract barely moves the scale: Cochrane found 0.04 kg against control, and later meta-analyses 0.4 to 1.8 kg, largely tied to caffeine. High-EGCG extracts raised liver enzymes in 6.7% vs 0.7% on placebo, and the EU now caps EGCG below 800 mg a day.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed
11 min read·23 citations

Part of Weight-loss supplements and diet trends: what the trials show

Green tea extract does not cause meaningful weight loss. The Cochrane review of 12-week trials found a difference of 0.04 kg against control in the studies it could pool, and called any effect too small to be clinically important.[1] Later meta-analyses that report a significant result put it at roughly 0.4 to 1.8 kg, and much of that depends on the caffeine in the capsule.[3][4][6] The extract also carries a liver risk that brewed tea at normal amounts largely does not: in a year-long randomized trial, 6.7% of women on a high-EGCG extract had a rise in the liver enzyme ALT, against 0.7% on placebo.[14]

About this article. Written from the Cochrane review and later meta-analyses of randomized trials, the largest long-term trial of green tea extract, the U.S. Drug-Induced Liver Injury Network’s case series, NIH’s LiverTox reference, the European Food Safety Authority’s 2018 opinion and the EU regulation that followed it. It covers concentrated extracts sold as supplements and fat burners, not tea as a drink. Nothing here is a reason to start or stop a medicine.

The evidence at a glance

What each kind of evidence on green tea extract and weight shows.
SourceWhat it foundLimits
Cochrane review, 2012−0.04 kg vs control in six pooled trials outside Japan; not significantTrials of 12 to 13 weeks; Japanese trials too different to pool
Meta-analyses, 2009–2025Significant losses of about 0.4 to 1.8 kgMixed doses, short trials, effect tied to caffeine
Minnesota Green Tea TrialNo change in BMI, fat mass or body fat after 12 months of decaffeinated extractPostmenopausal women only
Calorie-burn studiesRaised resting metabolic rate in only two of 15 studiesSmall, short and varied
Liver safety, randomizedALT rises in 6.7% on extract vs 0.7% on placeboOne high dose, 843 mg EGCG a day
Liver safety, case series3% of adjudicated U.S. drug-induced liver injury cases attributed to green teaCannot give a rate per user

What the Cochrane review found

The Cochrane Collaboration reviewed randomized trials of green tea preparations lasting at least 12 weeks in adults with overweight or obesity. The trials split into two groups so different that they could not be combined: those run in Japan and those run elsewhere.[1]

  • Outside Japan: six trials, 532 participants, a weight difference of −0.04 kg with a confidence interval from −0.5 to +0.4 kg. BMI moved 0.2 points and waist 0.2 cm, neither significant.[1]
  • In Japan: eight trials, 1,030 participants, differences from −0.2 to −3.5 kg in favor of green tea, which were too inconsistent to pool into one figure.[1]
  • Keeping weight off: two trials, 184 people, results ranging from a 0.6 kg gain to a 1.6 kg loss. The review found no significant effect on maintenance.[1]
Because the amount of weight loss is small, it is not likely to be clinically important.
— Jurgens et al., Cochrane Database of Systematic Reviews, 2012

The review is from 2012 and the trials in it were short, which is its main weakness and the reason the later analyses matter.

The later meta-analyses: significant, and still small

Analyses that pooled trials differently, or added newer ones, have mostly reported a statistically significant loss. The size of it has not grown.

  • Hursel 2009 (11 studies): −1.31 kg. In people who already drank more than 300 mg of caffeine a day the estimate fell to −0.27 kg, against −1.60 kg in low caffeine users, though that gap missed significance.[2]
  • Phung 2010 (15 studies, 1,243 people): catechins plus caffeine cut weight by 1.38 kg against caffeine alone, but by only 0.44 kg against a caffeine-free control. Catechins without caffeine showed no benefit on any measure.[3]
  • Lin 2020: −1.78 kg and −0.65 BMI points.[4]
  • Asbaghi 2024 (59 trials, 3,802 people): weight, BMI and body fat percentage fell; fat mass itself did not change. The authors rated the certainty of the evidence from low to high depending on the outcome.[5]
  • Dehzad 2025: −0.74 kg, −0.29 BMI points, 1 cm off the waist and 0.65 points of body fat percentage.[6]
  • With exercise (10 trials): adding green tea to an exercise program produced what the authors called “quite minimal” additional weight loss.[8]

Magnitude comparison

Weight lost beyond control in pooled analyses of green tea preparations, against semaglutide in its main weight trial. Rows come from different trials, people and lengths of treatment, so compare scale, not exact gaps.[1][2][3][6][23]

  • Semaglutide 2.4 mg, STEP 112.7 kg
    68 weeks; 15.3 kg vs 2.6 kg on placebo
  • Green tea, Hursel meta-analysis1.31 kg
    11 studies
  • Green tea, Dehzad meta-analysis0.74 kg
    2025, adults
  • Catechins + caffeine vs caffeine-free control0.44 kg
    Phung, 15 studies
  • Green tea, Cochrane, trials outside Japan0.04 kg
    not statistically significant
Weight lost beyond control in pooled analyses of green tea preparations, against semaglutide in its main weight trial. Rows come from different trials, people and lengths of treatment, so compare scale, not exact gaps.

The most favorable pooled estimate for green tea is about a seventh of the placebo-adjusted loss in semaglutide’s first weight trial, which was 12.7 kg over 68 weeks.[23] Even the estimates that reach statistical significance amount to a few pounds at most.

Why the results disagree

Caffeine. Many extracts contain it, and caffeine has its own small effect on energy use. When Phung separated the two, catechins alone did nothing measurable.[3] A capsule that works only when it contains caffeine is, in effect, a caffeine product. For what caffeine does alongside a GLP-1 drug, see coffee and caffeine on a GLP-1.

Where the trials ran. Japanese trials showed larger and more variable effects than Western ones, which is why Cochrane could not pool them.[1] Hursel saw the same pattern by ethnicity and habitual caffeine intake.[2]

Length. Most trials ran around 12 weeks. The longest well-run test points the other way. The Minnesota Green Tea Trial gave postmenopausal women a decaffeinated extract containing 843 mg of EGCG, the main green tea catechin, every day for a year. Among 121 participants with overweight or obesity, BMI, total fat mass and body fat percentage did not differ from placebo; body fat percentage fell by exactly the same 0.15 points in both groups.[7]

The metabolism claim

The fat-burner pitch for green tea extract rests on catechins raising energy expenditure. A systematic review of 15 studies of catechin supplements found a lower respiratory quotient, a sign of burning relatively more fat, but an increase in resting metabolic rate in only two studies: one of 44 calories a day and one of 261, with the gains seen mainly when participants were also doing resistance training.[9] As with capsaicin, a measurable change in metabolism has not turned into a meaningful change on the scale. Our page on capsaicin and capsinoids walks through the same pattern for another thermogenic ingredient.

Is green tea extract a “GLP-1” supplement?

It turns up in products marketed as natural GLP-1 boosters. The human evidence behind that is one randomized trial in 92 people with type 2 diabetes who took 500 mg of extract three times a day for 16 weeks. GLP-1 rose from baseline in the extract group, but the authors reported that improvement only within that group; compared against placebo, the only difference was a trend in triglycerides.[10] A within-group rise without a difference from placebo does not show the extract did anything. Even a real rise in natural GLP-1 lasts minutes, not the days a drug provides, which our review of GLP-1 supplements explains.

The liver problem

NIH’s LiverTox reference states that green tea extract, and more rarely very large amounts of green tea, has been implicated in acute liver injury, including liver failure that led to an urgent transplant or death.[11] Three kinds of evidence back that up.

A randomized trial

The Minnesota trial, built to study breast cancer markers, is the cleanest test because 1,075 women were randomized and followed for a year. ALT, the main blood marker of liver cell damage, rose in 36 women on the extract (6.7%) against 4 on placebo (0.7%), and 1.3% of those on the extract had an ALT-related serious adverse event. Nausea was also more common on the extract.[14] A follow-up analysis of women who started with normal liver tests found ALT rose by an average of 5.4 U/L on the extract, and the odds of a moderate or worse liver abnormality were 7 times those on placebo. In women who stopped and restarted, ALT fell back to normal and then rose again, the pattern that most strongly ties an injury to a substance.[15]

Shorter trials look calmer. A review of 34 randomized trials of green tea extracts found liver-related adverse events in seven people on the extract and one on control, an odds ratio of 2.1 with a confidence interval from 0.5 to 9.8, and judged such events likely to be rare.[21] With eight events in total, that estimate is too imprecise to rule a risk in or out.

The U.S. liver injury registry

The NIH-funded Drug-Induced Liver Injury Network (DILIN) adjudicates suspected cases from U.S. hospitals. Of 1,414 assessed cases, 40 (3%) were attributed to green tea. The injury typically appeared about ten weeks after starting, with a median of 72 days and a range of 15 to 448. Most patients were jaundiced (83%), 35% of cases were severe, and three people needed a liver transplant. In three, the injury came back on re-exposure.[16]

The same study found a genetic marker. HLA-B*35:01 was present in 72% of green tea cases, against 12% of people injured by conventional drugs and 11% of the general population, which suggests an immune reaction in susceptible people rather than simple overdose.[16]

Dose, fasting and the empty stomach

A 2020 review by the U.S. Pharmacopeia (USP), the body that sets quality standards for medicines and supplements, linked published liver cases to EGCG intakes from 140 mg to about 1,000 mg a day, with large differences in who was susceptible. It also found that taking a concentrated dose on an empty stomach sharply increases how much EGCG reaches the blood.[19] USP had first reviewed the question in 2008, after France and Spain suspended a green tea weight-loss product; it classified 7 of 34 liver case reports as probably caused by green tea.[20]

Do not take on an empty stomach. Take with food. Do not use if you have a liver problem and discontinue use and consult a healthcare practitioner if you develop symptoms of liver trouble, such as abdominal pain, dark urine, or jaundice (yellowing of the skin or eyes).
— USP cautionary labeling for powdered decaffeinated green tea extract

What European regulators did

In 2018 the European Food Safety Authority (EFSA) reviewed green tea catechins from all sources. It concluded that tea brewed the traditional way is generally safe at normal intakes, which in Europe deliver 90 to 300 mg of EGCG a day. Supplements, by contrast, provide anywhere from 5 to 1,000 mg. EFSA found that trials giving 800 mg of EGCG a day or more as a supplement produced a significant rise in liver enzymes compared with control.[12] It could not identify any intake of green tea catechins that raised no concern.[13]

The European Commission acted in 2022. Under Regulation (EU) 2022/2340, a daily portion of a food or supplement containing green tea extract must hold less than 800 mg of EGCG, the label must state the EGCG per portion, and it must carry three warnings: not to be used alongside other green tea products on the same day, not by pregnant or breastfeeding women or under-18s, and not on an empty stomach. Extracts below that line were placed under formal EU scrutiny because harm at lower doses could not be ruled out.[13] Ordinary tea-like drinks are excluded.

800 mg is a ceiling, not a safe dose. The EU cap marks the level at which trials showed liver enzyme rises. EFSA could not name any catechin intake it considered free of concern, and published liver injury cases include intakes as low as 140 mg a day.[13][19]

Fat burners: where the liver cases come from

Green tea extract is rarely sold alone. It is a staple of multi-ingredient weight-loss products, which makes individual cases hard to pin on one ingredient. DILIN described six women, aged 22 to 58, injured by products in a single weight-loss line; five of the six products listed green tea extract or catechins. Five had ALT above 1,000 U/L, three were hospitalized and one received a transplant.[17] A separate DILIN series of 22 liver injuries from garcinia cambogia products found that 16 also contained green tea; one patient died, one needed a transplant, and the investigators described the injuries from garcinia and from green tea as “clinically indistinguishable.”[18]

Use is common. A national survey estimated that 15.6 million U.S. adults had taken at least one of six botanicals with known liver risk in the previous month, about as many as were taking simvastatin or anti-inflammatory painkillers, two drug types with known liver risk; green tea was the second most-used of the six.[22]

Green tea extract on a GLP-1 drug

No trial has tested green tea extract alongside Ozempic, Wegovy, Mounjaro or Zepbound, so there is no evidence it adds weight loss to them. With an effect this small on its own, any added benefit would be hard to detect.

The practical issue is the liver panel. GLP-1 drugs tend to lower liver enzymes on average as weight comes off, so a rising ALT on one of them prompts a search for another cause, and supplements are on that list. Our page on GLP-1 drugs, liver damage and liver enzymes sets out how prescribers work through a raised result. Anyone with fatty liver disease, which many people starting these drugs have, falls under the USP caution about existing liver problems.[19] For what GLP-1 treatment itself does to fatty liver, see GLP-1 drugs and fatty liver disease. Nausea is also the most common GLP-1 side effect, and it was more frequent on high-dose extract in the Minnesota trial.[14]

If you take it anyway

  • Check the label for EGCG per serving, not just milligrams of “extract”; extract strength varies widely with how it is made.[19]
  • Count every product: fat burners, pre-workouts and “GLP-1” blends can each contain green tea extract.
  • Take it with food, never on an empty stomach.[13][19]
  • Tell whoever orders your blood tests, especially on a GLP-1 drug or with known liver disease.
  • Stop and get a liver check for abdominal pain, tea-colored urine, or yellow skin or eyes. In the DILIN series, injury usually appeared weeks to months after starting, not on the first day.[16]

For graded entries on berberine, fiber and other weight-loss supplements, see the supplement evidence grader, and for a fat burner with no human trial behind it at all, see raspberry ketones.

Frequently Asked Questions

Very little, if at all. The Cochrane review found a 0.04 kg difference against control in pooled trials outside Japan and judged the effect not clinically important. Later meta-analyses report significant losses of roughly 0.4 to 1.8 kg, much of it linked to caffeine in the product.
It can be. In a year-long randomized trial, 6.7% of women taking extract with 843 mg of EGCG a day had a rise in the liver enzyme ALT, against 0.7% on placebo. The U.S. Drug-Induced Liver Injury Network attributes 3% of its adjudicated cases to green tea, some needing transplants. Injury is uncommon but can be severe.
No. Europe's food safety agency considers traditionally brewed green tea generally safe at normal intakes, which provide about 90 to 300 mg of EGCG a day. Supplements can provide up to 1,000 mg, often in a single dose, and the liver injury cases are mainly tied to concentrated extracts.
No regulator has named a safe amount. Europe's food safety agency found liver enzyme rises at 800 mg a day or more and could not identify a lower intake free of concern. The EU now limits a daily portion to under 800 mg, with warnings not to take it on an empty stomach or with other green tea products.
No trial has tested the combination, and there is no evidence it adds weight loss. The drugs usually lower liver enzymes as weight falls, so a supplement that can raise them complicates reading a liver test. Tell the prescriber about any green tea product, especially with fatty liver disease.

References

  1. 1.Jurgens TM, Whelan AM, Killian L, Doucette S, Kirk S, Foy E Green tea for weight loss and weight maintenance in overweight or obese adults Cochrane Database of Systematic Reviews. 2012. PMID: 23235664.
  2. 2.Hursel R, Viechtbauer W, Westerterp-Plantenga MS The effects of green tea on weight loss and weight maintenance: a meta-analysis International Journal of Obesity. 2009. PMID: 19597519.
  3. 3.Phung OJ, Baker WL, Matthews LJ, Lanosa M, Thorne A, Coleman CI Effect of green tea catechins with or without caffeine on anthropometric measures: a systematic review and meta-analysis American Journal of Clinical Nutrition. 2010. PMID: 19906797.
  4. 4.Lin Y, Shi D, Su B, Wei J, et al. The effect of green tea supplementation on obesity: a systematic review and dose-response meta-analysis of randomized controlled trials Phytotherapy Research. 2020. PMID: 32372444.
  5. 5.Asbaghi O, Rezaei Kelishadi M, Larky DA, Bagheri R, et al. The effects of green tea extract supplementation on body composition, obesity-related hormones and oxidative stress markers: a grade-assessed systematic review and dose-response meta-analysis of randomised controlled trials British Journal of Nutrition. 2024. PMID: 38031409.
  6. 6.Dehzad MJ, Ghalandari H, Fahimzad FS, Maghsoudi Z, et al. Effects of green tea supplementation on obesity indices and adipokines in adults: a grade-assessed systematic review and dose-response meta-analysis of randomised controlled trials International Journal of Food Sciences and Nutrition. 2025. PMID: 40326418.
  7. 7.Dostal AM, Arikawa A, Espejo L, Kurzer MS Long-term supplementation of green tea extract does not modify adiposity or bone mineral density in a randomized trial of overweight and obese postmenopausal women Journal of Nutrition. 2016. PMID: 26701796.
  8. 8.Gholami F, Antonio J, Iranpour M, Curtis J, Pereira F Does green tea catechin enhance weight-loss effect of exercise training in overweight and obese individuals? A systematic review and meta-analysis of randomized trials Journal of the International Society of Sports Nutrition. 2024. PMID: 39350601.
  9. 9.Rondanelli M, Riva A, Petrangolini G, Allegrini P, et al. Effect of acute and chronic dietary supplementation with green tea catechins on resting metabolic rate, energy expenditure and respiratory quotient: a systematic review Nutrients. 2021. PMID: 33671139.
  10. 10.Liu CY, Huang CJ, Huang LH, Chen IJ, Chiu JP, Hsu CH Effects of green tea extract on insulin resistance and glucagon-like peptide 1 in patients with type 2 diabetes and lipid abnormalities: a randomized, double-blinded, and placebo-controlled trial PLoS One. 2014. PMID: 24614112.
  11. 11.National Institute of Diabetes and Digestive and Kidney Diseases Green Tea. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury NIH, Bethesda (MD); updated November 2020. 2012. PMID: 31643260.
  12. 12.Younes M, Aggett P, Aguilar F, et al. (EFSA Panel on Food Additives and Nutrient Sources added to Food) Scientific opinion on the safety of green tea catechins EFSA Journal. 2018. PMID: 32625874.
  13. 13.European Union Commission Regulation (EU) 2022/2340 of 30 November 2022 amending Annex III to Regulation (EC) No 1925/2006 as regards green tea extracts containing (−)-epigallocatechin-3-gallate Official Journal of the European Union. 2022. https://eur-lex.europa.eu/eli/reg/2022/2340/oj
  14. 14.Dostal AM, Samavat H, Bedell S, Torkelson C, et al. The safety of green tea extract supplementation in postmenopausal women at risk for breast cancer: results of the Minnesota Green Tea Trial Food and Chemical Toxicology. 2015. PMID: 26051348.
  15. 15.Yu Z, Samavat H, Dostal AM, Wang R, et al. Effect of green tea supplements on liver enzyme elevation: results from a randomized intervention study in the United States Cancer Prevention Research. 2017. PMID: 28765194.
  16. 16.Hoofnagle JH, Bonkovsky HL, Phillips EJ, Li YJ, et al.; Drug-Induced Liver Injury Network HLA-B*35:01 and green tea-induced liver injury Hepatology. 2021. PMID: 32892374.
  17. 17.Zheng EX, Rossi S, Fontana RJ, Vuppalanchi R, Hoofnagle JH, Khan I, Navarro VJ Risk of liver injury associated with green tea extract in SLIMQUICK weight loss products: results from the DILIN prospective study Drug Safety. 2016. PMID: 27189593.
  18. 18.Vuppalanchi R, Bonkovsky HL, Ahmad J, Barnhart H, et al.; Drug-Induced Liver Injury Network Garcinia cambogia, either alone or in combination with green tea, causes moderate to severe liver injury Clinical Gastroenterology and Hepatology. 2022. PMID: 34400337.
  19. 19.Oketch-Rabah HA, Roe AL, Rider CV, Bonkovsky HL, et al. United States Pharmacopeia (USP) comprehensive review of the hepatotoxicity of green tea extracts Toxicology Reports. 2020. PMID: 32140423.
  20. 20.Sarma DN, Barrett ML, Chavez ML, Gardiner P, et al. Safety of green tea extracts: a systematic review by the US Pharmacopeia Drug Safety. 2008. PMID: 18484782.
  21. 21.Isomura T, Suzuki S, Origasa H, Hosono A, et al. Liver-related safety assessment of green tea extracts in humans: a systematic review of randomized controlled trials European Journal of Clinical Nutrition. 2016. PMID: 27188915.
  22. 22.Likhitsup A, Chen VL, Fontana RJ Estimated exposure to 6 potentially hepatotoxic botanicals in US adults JAMA Network Open. 2024. PMID: 39102266.
  23. 23.Wilding JPH, Batterham RL, Calanna S, Davies M, et al. Once-weekly semaglutide in adults with overweight or obesity New England Journal of Medicine. 2021. PMID: 33567185.

Garcinia Cambogia: What the Weight-Loss and Liver Evidence Shows

Garcinia cambogia does not produce meaningful weight loss. In the 1998 JAMA trial, people on hydroxycitric acid lost 3.2 kg vs 4.1 kg on placebo. What the meta-analyses, liver-injury registry, Hydroxycut recall and FTC cases show.

11 min read

Can Ozempic or Mounjaro Cause Liver Damage? Liver Enzymes Evidence Review

Liver injury on semaglutide or tirzepatide is rare. Trial ALT levels fall on average, no label carries a liver warning, and about 31 suspected cases have been published. Gallstones are the likelier cause of a raised liver test, and jaundice or dark urine needs same-day care.

11 min read

Coffee on Ozempic, Wegovy or Mounjaro: What the Labels and Studies Say

You can drink coffee on Ozempic, Wegovy, Mounjaro or Zepbound; no label mentions it. Semaglutide tablets are the exception: a small glass of water alone, and coffee held for half an hour. What coffee does to reflux, heart rate, hydration and blood sugar on a GLP-1.

11 min read

Akkermansia muciniphila: What the Human Trials Show About Weight and GLP-1

Akkermansia is sold as a natural GLP-1 booster. Seven small randomized trials exist: one cut weight regain by about 2 kg, the largest missed its primary endpoint, and most were run by the maker. EU authorization, US status, and what GLP-1 drugs do to it.

11 min read

Does Spirulina Help With Weight Loss? What Small Trials Found

Spirulina trials show about 0.8 to 1.9 kg of extra weight loss in small, short studies. It modestly lowers cholesterol and blood pressure, carries little protein at real doses, does not act like a GLP-1, and algae supplements have tested positive for liver toxins.

9 min read

L-Carnitine Injections for Weight Loss: What the Evidence Shows

No trial shows L-carnitine shots cause weight loss. Oral carnitine trials average about 1.2 kg over placebo; the only approved injection, Carnitor, is for deficiency and dialysis, IV only. What TMAO studies show, and what carnitine adds to a GLP-1 vial.

11 min read

Where to get GLP-1 online, safely: sellers our editors have checked

These are telehealth sellers our editors have checked. For each one we hold a price, the form the drug comes in, and the states it reaches.

No insurance needed · vetted by our editors

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

7.7

Luvo Health

Moving between compounded and brand without changing seller

8.6

Strut Health

Semaglutide at $99/month, well below the typical price

7.4

Enhance MD

Knowing which pharmacy fills the vial: it names Tru Meds Rx

About this analysis

GLP Watchdog publishes independently. Each seller in our dataset is checked against that seller's own website, and the dataset is updated continuously. Read our full methodology →